OA02.03 Tumor Bulk-RNA Seq Identifies Patients at High Risk of Progression in Non-complete Pathological Responders from NADIM Trial
Journal of Thoracic Oncology(2022)
Key words
stage IIIA NSCLC,pathological response,Tumor Bulk-RNA seq
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined